Yuichi Komine
Directeur/Membre du Conseil chez ONCOTHERAPY SCIENCE, INC.
Postes actifs de Yuichi Komine
Sociétés | Poste | Début | Fin |
---|---|---|---|
ONCOTHERAPY SCIENCE, INC. | Directeur/Membre du Conseil | 01/09/2014 | - |
Comptroller/Controller/Auditor | 01/06/2008 | 01/09/2014 | |
SUN-LIFE HOLDING CO.,LTD. | Directeur/Membre du Conseil | 01/10/2018 | - |
G&G Science Co., Ltd.
G&G Science Co., Ltd. Miscellaneous Commercial ServicesCommercial Services G&G Science Co., Ltd. provides research and development services for DNA analysis and consulting. The private company is based in Fukushima, Japan. | Comptroller/Controller/Auditor | 01/04/2005 | - |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Directeur/Membre du Conseil | 01/02/2017 | - |
Sun Life Members Co., Ltd. | Comptroller/Controller/Auditor | 01/11/2011 | - |
Historique de carrière de Yuichi Komine
Statistiques
Internationale
Japon | 6 |
Opérationnelle
Comptroller/Controller/Auditor | 3 |
Director/Board Member | 3 |
Sectorielle
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ONCOTHERAPY SCIENCE, INC. | Health Technology |
SUN-LIFE HOLDING CO.,LTD. | Consumer Services |
Entreprise privées | 3 |
---|---|
G&G Science Co., Ltd.
G&G Science Co., Ltd. Miscellaneous Commercial ServicesCommercial Services G&G Science Co., Ltd. provides research and development services for DNA analysis and consulting. The private company is based in Fukushima, Japan. | Commercial Services |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
Sun Life Members Co., Ltd. |
- Bourse
- Insiders
- Yuichi Komine
- Expérience